ERBB2 and breast carcinoma: Breast cancers in women less than 40 years of age are more likely to be clinicopathologically characterized by higher histological grade, higher rates of Her2/neu overexpression, lower estrogen receptor (ER) positivity, and more lymph node positivity [8].